Bonothyrk A-21 Parathyroid Peptide Bioregulator

Bonothyrk A-21 Parathyroid Peptide Bioregulator (also known as BioParathyroid or Peptide Complex A-21) is a natural oral peptide bioregulator from the Cytomax range developed through research associated with Professor Vladimir Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology.

It consists of a complex of low-molecular-weight peptides (typically under 5,000 Da) isolated from the parathyroid glands of young, healthy animals (usually bovine or porcine sources under controlled conditions). These tissue-specific peptides are designed to support the functional activity and metabolism of parathyroid gland cells.

Unlike synthetic parathyroid hormone (PTH) drugs such as teriparatide, Bonothyrk is a dietary supplement containing a crude peptide fraction rather than a single defined molecule. It aims to help reduce age- or stress-related peptide deficiency and support protein synthesis within target cells.

How Does Bonothyrk A-21 Work?

The parathyroid glands regulate calcium and phosphate levels in blood and bones—minerals essential for nerve signaling, muscle contraction, and skeletal integrity.

According to the peptide bioregulator concept, short signaling peptides can interact with DNA promoter regions, influencing gene expression and cellular protein synthesis in a tissue-specific manner. Bonothyrk peptides are claimed to selectively target parathyroid cells, helping normalize intracellular metabolism and support the glands’ regulatory role.

This may contribute to healthier calcium-phosphate homeostasis without the systemic effects of conventional hormone therapies.

Key Potential Benefits of Bonothyrk A-21

Manufacturer and product literature associate Bonothyrk with support in the following areas (these are not FDA-evaluated claims; the product is a dietary supplement):

• Calcium and phosphate balance — Supports healthy mineral levels critical for nervous and musculoskeletal systems.
• Bone health and mineral density — May help maintain bone structure; some reported observational data in women with elevated osteoporosis risk noted improvements after a 30-day course.
• Parathyroid gland function — Helps normalize metabolism of parathyroid cells and may assist in age-related or functional decline.
• Musculoskeletal comfort — Linked in product materials to reduced muscle weakness, cramps, numbness, or spasms related to mineral imbalance.
• Healthy aging support — Part of broader peptide bioregulator approaches to organ-specific maintenance.

Note: Independent reviews highlight that robust, peer-reviewed clinical evidence specifically for Bonothyrk is limited or thin (few or no indexed PubMed studies on the exact product). Benefits are primarily drawn from platform research on bioregulators, manufacturer data, and traditional use in certain regions.

Suggested Use and Dosage

Typical recommendations from product labels and distributors (always follow the specific product instructions and consult a healthcare professional):

• Standard course: 1–2 capsules, 1–2 times daily with or before meals.
• Intensive protocol (common): 2 capsules daily for 30 days (often 60 capsules total).
• Maintenance: 2 capsules daily for 10 days every 1–3 or 3–6 months.
• Course length is frequently listed as 10–60 days depending on goals.

Each capsule commonly contains approximately 10–40 mg of Peptide Complex A-21 (parathyroid peptides), with inactive ingredients such as microcrystalline cellulose, calcium stearate, and a vegetarian or gelatin capsule. Products are generally gluten-free and non-GMO.

Storage: Cool, dry place (typically +2°C to +25°C), away from children. Contraindications: Individual intolerance, pregnancy, and lactation are commonly listed. Not intended to diagnose, treat, cure, or prevent any disease.

Who May Consider Bonothyrk A-21?

Adults interested in targeted nutritional support for:

• Maintaining calcium balance and bone wellness
• Supporting parathyroid function as part of healthy aging or mobility routines
• Complementary approaches alongside lifestyle measures for skeletal resilience

It is sometimes paired with other Cytomax bioregulators (e.g., those for vessels, cartilage, or immune support) in comprehensive protocols.

Frequently Asked Questions

Is Bonothyrk the same as parathyroid hormone? No. It is an oral peptide extract, not a pharmaceutical PTH analog.

What is the evidence level? Evidence is primarily from Russian research institutes and manufacturer reports. Western independent clinical data remain limited.

Is it safe? Product literature describes a favorable tolerability profile with no major adverse effects reported in available materials. As with any supplement, individual responses vary.

How long until effects may be noticed? Some users and reports mention changes related to mineral balance or comfort within a full 30-day course; results are individual.